Evidence map›Paper›PMID 32983061›Full record

ArticleFrontiers in microbiology2020

Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on

Anna Gidari, Samuele Sabbatini, Elisabetta Schiaroli, Stefano Perito, Daniela Francisci, Franco Baldelli, Claudia Monari

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Antibiofilm approaches as a new paradigm for treating infections.Progress in biomedical engineering (Bristol, England) · 2024
    Review
  5. Article
  6. Article
  7. Tedizolid: new data and experiences for clinical practice.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2021
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anna GidariDepartment of Medicine, Clinic of Infectious Diseases, University of Perugia, Perugia, Italy.
Samuele SabbatiniDepartment of Medicine, Medical Microbiology Section, University of Perugia, Perugia, Italy.
Elisabetta SchiaroliDepartment of Medicine, Clinic of Infectious Diseases, University of Perugia, Perugia, Italy.
Stefano PeritoDepartment of Medicine, Medical Microbiology Section, University of Perugia, Perugia, Italy.
Daniela FrancisciDepartment of Medicine, Clinic of Infectious Diseases, University of Perugia, Perugia, Italy.
Franco BaldelliDepartment of Medicine, Clinic of Infectious Diseases, University of Perugia, Perugia, Italy.
Claudia MonariDepartment of Medicine, Medical Microbiology Section, University of Perugia, Perugia, Italy.
University of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibiotic resistancebiofilmdaptomycinrifampicinS. aureustedizolid

Identifiers

PMID32983061
PMCPMC7484889
OpenAlexW3081993601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.